CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company
BriaCell Therapeutics Corp.
Sign in to watch- Ticker
- BCTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 921-1810
- Business address
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
- Former names
- Ansell Capital Corp.
Securities
- BCTX Common Shares Nasdaq
- BCTXL Warrants Nasdaq
- BCTXZ Warrant Nasdaq
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Unregistered share sale
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 8 of 17 · 324 filings